Affymetrix GSC3000 microarray scanner

Affymetrix GSC3000 微阵列扫描仪

• 批准号: 6877397
• 负责人: MICHAEL MCCLELLAND
• 金额: $ 13.58万
• 依托单位: SIDNEY KIMMEL CANCER CENTER
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-01-14 至 2006-01-13
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6877397
• 关键词: biomedical equipment purchase; biomedical equipment resource; biotechnology; microarray technology

DESCRIPTION (provided by applicant): The Sidney Kimmel Cancer Center is a nonprofit research institute founded in 1991 with USPH grant supported research programs in cancer genetics, cell biology, hematology and hematopoiesis and immunology, and vascular biology. The center has grown rapidly to 23 investigators and over 170 support staff. The Sidney Kimmel Cancer Center Campus consists of two buildings, one recently constructed, and includes the last two undeveloped lots on Torrey Pines Mesa. Building of research facilities on these lots will commence within the year. The Genome Core at SKCC was begun in 1995 and currently has 1.25 FTE providing services in Q-PCR, liquid handling robotics, custom array manufacture, and Affymetrix microarrays. The proposed purchase of the new Affymetrix microarray scanner and fluidics station will allow the continued operation of the Affymetrix service, while decreasing the array costs per gene by fourfold, and increasing throughput with improved machine design. Six major and twenty two other users have been identified at SKCC whose research programs either require this system or would be significantly enhanced by continued access to this technology. All of the major users and many of the other users have already used this system. One of the highlights includes two separate groups that have used the Affymetrix system to identify genes that appear to be important in prostate cancer progression.

描述（由申请人提供）：Sidney Kimmel癌症中心是一个非营利性研究机构，成立于1991年，由USPH资助，研究项目包括癌症遗传学、细胞生物学、血液学、造血和免疫学以及血管生物学。该中心迅速发展到23名调查员和170多名支持人员。Sidney Kimmel癌症中心校园由两栋建筑组成，其中一栋是最近建造的，其中包括Torrey Pines Mesa上最后两个未开发的地块。在这些地段兴建研究设施将于年内展开。